Audio is streamed directly from the publisher (play.hubhopper.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
In this episode of Hormone Insight, we delve into a major study published in The Lancet Diabetes and Endocrinology that compared the effects of semaglutide and canagliflozin as add-ons to metformin in diabetes treatment.
For more: Semaglutide vs Canagliflozin for Type 2 Diabetes
To read the original paper